Phibro Animal Health annual stock-based compensation
2017
2018
2019
2020
2021
2023
2024
2025
2026
Phibro Animal Health Stock-Based Compensation Growth & History (PAHC)
Phibro Animal Health's stock-based compensation was $1.6M for fiscal 2026.
View full Phibro Animal Health company overviewPhibro Animal Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $1.6M | $880,000 | +122.73% |
| 2025 | 2025-06-30 | $717,000 | $242,000 | +50.95% |
| 2024 | 2024-06-30 | $475,000 | $475,000 | — |
| 2023 | 2023-06-30 | $0 | — | — |
| 2021 | 2021-06-30 | $1.1M | −$1.1M | −50.02% |
| 2020 | 2020-06-30 | $2.3M | $0 | 0.00% |
| 2019 | 2019-06-30 | $2.3M | $1.9M | +576.35% |
| 2018 | 2018-06-30 | $334,000 | $334,000 | — |
| 2017 | 2017-06-30 | $0 | — | — |
Phibro Animal Health quarterly stock-based compensation
Q1.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | $413,000 | $234,000 | +130.73% |
| Q3 2026 | 2026-03-31 | $411,000 | $232,000 | +129.61% |
| Q2 2026 | 2025-12-31 | $434,000 | $254,000 | +141.11% |
| Q1 2026 | 2025-09-30 | $339,000 | $160,000 | +89.39% |
| Q4 2025 | 2025-06-30 | $179,000 | $0 | 0.00% |
| Q3 2025 | 2025-03-31 | $179,000 | $44,000 | +32.59% |
| Q2 2025 | 2024-12-31 | $180,000 | $100,000 | +125.00% |
| Q1 2025 | 2024-09-30 | $179,000 | $98,000 | +120.99% |
| Q4 2024 | 2024-06-30 | $179,000 | — | — |
| Q3 2024 | 2024-03-31 | $135,000 | — | — |
| Q2 2024 | 2023-12-31 | $80,000 | — | — |
| Q1 2024 | 2023-09-30 | $81,000 | — | — |
| Q3 2022 | 2022-03-31 | $0 | $0 | — |
| Q2 2022 | 2021-12-31 | $0 | −$564,000 | — |
| Q1 2022 | 2021-09-30 | $0 | −$565,000 | — |
| Q4 2021 | 2021-06-30 | $0 | −$565,000 | — |
| Q3 2021 | 2021-03-31 | $0 | −$565,000 | — |
| Q2 2021 | 2020-12-31 | $564,000 | $0 | 0.00% |
| Q1 2021 | 2020-09-30 | $565,000 | $0 | 0.00% |
| Q4 2020 | 2020-06-30 | $565,000 | — | — |
| Q3 2020 | 2020-03-31 | $565,000 | $0 | 0.00% |
| Q2 2020 | 2019-12-31 | $564,000 | — | — |
| Q1 2020 | 2019-09-30 | $565,000 | $0 | 0.00% |
| Q3 2019 | 2019-03-31 | $565,000 | — | — |
| Q1 2019 | 2018-09-30 | $565,000 | — | — |
Phibro Animal Health stock-based compensation trends
Over the last five fiscal years, Phibro Animal Health's stock-based compensation increased from $1.1M to $1.6M, a change of $468,000. The latest reported quarter, Q4 2026, shows $413,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phibro Animal Health source filings ↗